Tootsie Roll Industries (TR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual Meeting scheduled for May 5, 2025, to elect five directors and ratify Grant Thornton LLP as auditor for fiscal 2025.
Only shareholders of record as of March 5, 2025, are entitled to vote; Common Stock has one vote per share, Class B Common Stock has ten votes per share.
Board recommends voting for all director nominees and for auditor ratification.
Voting matters and shareholder proposals
Shareholders will vote on the election of five directors and the ratification of Grant Thornton LLP as independent auditor.
Shareholders may submit proposals for the 2026 Annual Meeting by November 27, 2025, and must follow advance notice procedures for nominations.
Board of directors and corporate governance
Board consists of five nominees, including the CEO; most non-management directors are independent under NYSE standards.
Board combines Chairman and CEO roles; no lead independent director.
Board reviews succession planning for senior management and maintains a Code of Business Conduct and Ethics.
Board does not have a separate nominating committee due to controlled company status.
Latest events from Tootsie Roll Industries
- Net earnings and margins declined in Q2 2026 as higher costs and promotions pressured results.TR
Q2 2026 - Net sales rose 2% to $149.5M, but higher costs and taxes reduced net earnings to $17.7M.TR
Q1 2026 - Proxy covers director elections, auditor ratification, and executive pay, with strong governance.TR
Proxy filing - 2025 earnings rose on higher sales and margin recovery, with input costs and tariffs easing ahead.TR
Q4 2025 - Q3 2025 saw higher sales, earnings, and margins, but input costs and tariffs remain risks.TR
Q3 2025 - Q2 sales and earnings rose, but margin risks from cocoa costs and tariffs persist.TR
Q2 2025 - Q3 sales fell nearly 10%, but margins and EPS improved; cocoa costs and pension risks persist.TR
Q3 2024 - Earnings and EPS rose despite lower sales, but margin pressure from high cocoa costs is expected.TR
Q2 2024 - Earnings rose 14% despite lower sales, but margin pressure from cocoa costs is expected ahead.TR
Q1 2025